The Adaptable Phage Solutions research programme will develop a phage discovery and development pipeline that can produce precise biocontrol phage combinations for the prevention, reduction, and treatment of bacterial pathogens.
Four key research phases:
- Develop precision phage combinations
- Scale production and formulate
- Test performance of phages as biocontrol agents
- Market acceptance and engagement
The development of this platform will be supported through work to gain insights into end-user views and enable discussion with these key stakeholders about the potential of phage biocontrol for New Zealand.
The programme will aim to create a new phage manufacturing bioindustry in New Zealand and with highly skilled jobs and will improve our food sectors’ productivity. Longer term, the platform will be positioned to pivot towards emerging threats to food production, and even medically relevant human pathogens.